Skip to content

The effect of high-definition individualized theta frequency transcranial alternating current stimulation on cognitive function in patients with post-stroke cognitive impairment: A randomized controlled trial

The effect of high-definition individualized theta frequency transcranial alternating current stimulation on cognitive function in patients with post-stroke cognitive impairment: A randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121224
Enrollment
Unknown
Registered
2026-03-26
Start date
2024-08-29
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Stroke Cognitive Impairment

Interventions

ITF group:ITF HD-tACS: The stimulation intensity is 1mA, with a stimulation duration of 20 minutes, applied continuously for 10 days, once per day.
5Hz group:5Hz HD-tACS: The stimulation intensity is 1mA, with a stimulation duration of 20 minutes, applied continuously for 10 days, once per day.
Sham group:sham stimulation: The stimulation intensity is 1mA, with a stimulation duration of 20 minutes, applied continuously for 10 days, once per day.

Sponsors

Center of Rehabilitation Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Montreal Cognitive Assessment Scale (MoCA) score <=25; 2.First-ever stroke, Cognitive impairment should occur within 12 months of the vascular event and last for at least 1 months; 3.Age 18 to 80 years, Right-handed; 4.Normal cognitive function before stroke; 5.Stable vital signs; 6.No severe vision, hearing impairment and capable of completing cognitive tests; 7.Obtain the consent of the patient and his family, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1.Complete damage to the left prefrontal cortex confirmed by CT/MRI; 2.Bilateral brain lesions; 3.Defect of the skull; 4.Use of antidepressants or psychostimulants; 5.Metal or cardiac pacemaker implants near the treatment site; 6.Brain disorders such as brain tumors, brain trauma, and seizures; 7.Unstable vital signs or failure of vital organs; 8.Any neuropsychiatric comorbidity or affective disorder that could affect the test results; 9.Patients are unable to cooperate with the cognitive assessment and intervention described below.

Design outcomes

Primary

MeasureTime frame
Montreal cognitive assessment;

Secondary

MeasureTime frame
Auditory Verbal Learning Test;Digit Span Test;Symbol Digit Modalities Test;Power spectral density;Adverse events;Phase locking value;

Countries

China

Contacts

Public ContactWang Kangling

Rehabilitation Medicine Center of Zhujiang Hospital, Southern Medical University

wkangling@126.com+86 159 8920 1852

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026